Get In Touch

Global Primary Immunodeficiency Disease Market to Expand with Advancements in Genetic Therapy

The presence of an industrious healthcare sector has played an integral role in driving demand within the global primary immunodeficiency disease market. The need to treat immunodeficiency disorders stems from the growing incidence of infections and tumours. The human immune system is responsible for averting several infectious diseases, and this is an important consideration from the standpoint of market growth. Besides, the increasing demand for improved treatment lines within medicine has also generated humongous revenues within the global primary immunodeficiency disease market. Occurrence of tumours in critical areas of the human body is also an outcome of a weak immune system. Medical research has attracted increased investments in recent times.

Transparency Market Research, in its report, finds that the global primary immunodeficiency disease market would expand at a robust CAGR of 6.10% over the period between 2015 and 2023. Furthermore, the total worth of the global immunodeficiency disease market is expected to touch US$7.5 bn by 2023-end, rising up from a value of US$4.3 bn in 2014. Various new therapeutics lines have been developed by medical researchers, and this trend has helped in offering improved treatments for genetic disorders. The growth of the global primary immunodeficiency disease market largely relies on advancements in medical research.

Some of the prominent vendors in the global primary immunodeficiency disease market are Baxter International, Inc., CSL Behring LLC, Grifols S.A., and Octapharma AG. These vendors are making ardent efforts to foster product innovation.

Advancements in Genetic Therapy to Drive Demand

Immunosuppression has emerged as an important form of therapy, and the medical fraternity has embraced it with a plush level of aplomb. Furthermore, immunodeficiencies are caused by a multitude of factors including genetic mutation. Considering the aforementioned factors, the medical industry has invested palpable resources in treating immunodeficiency disorders. Therefore, it legit to expect that the global primary immunodeficiency disease market would expand at a starry growth rate in the years to follow. Advancements in gene therapy have also helped the market vendors in tracing an ascending trajectory of growth. DNA sequencing is another key area related to the study of immune disorders.

Occurrence of Immune Diseases in Children

Genetic disorders in infants are easy to diagnose, and this is an important cue for healthcare professionals. Furthermore, diagnosis of persistent infections in children is also an important area of research for doctors. Therefore, the global primary immunodeficiency disease market is attracting increased attention from the healthcare fraternity. Multifactorial genetic defects can cause severe problems in ailing individuals, necessitating the need for swift treatment. As the healthcare industry undergoes continual overhauls, the global primary immunodeficiency disease market shall attract fresh revenues. Students and healthcare interns are subjected to core knowledge about immunodeficiency diseases in order to train them for the challenges within medical research.

The global primary immunodeficiency disease market can be segmented by:


  • Antibody Deficiency
    • Agammaglobulinaemia ((X-Linked and Autosomal Recessive)
    • Common Variable Immune Deficiency
    • Selective IgA Deficiency
    • IgG Subclass Deficiency
    • Others
  • Cellular Immunodeficiency
    • Ataxia Telangiectasia
    • Hyper IgM Syndromes
    • Wiskott-Aldrich Syndrome
    • DiGeorge Syndrome
    • Others
  • Innate Immune Disorders
    • Complement Deficiencies
    • Hyper IgE Syndrome
    • Others


  • Blood Test
  • Prenatal Testing


  • Immunoglobulin Replacement Therapy
  • Antibiotic Therapy
  • Stem cell and Gene Therapy
  • Others


  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Rest of the World

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem-solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact Us

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453

7 of 10 large enterprizes view our ToC to take the right decision.

View Report ToC